Personalized Nutrition and Dietary Interventions in Inflammatory Bowel Disease (IBD)

A special issue of Dietetics (ISSN 2674-0311).

Deadline for manuscript submissions: 15 December 2026 | Viewed by 2943

Special Issue Editor


E-Mail Website
Guest Editor
1. Center for Advancing Exercise and Nutrition Research on Aging, Florida State University, Tallahassee, FL 32304, USA
2. Department of Nutrition, Food and Exercise Sciences, Florida State University, Tallahassee, FL 32304, USA
Interests: functional foods; dietary supplements (e.g., vitamins, minerals, plant bioactive compounds); chronic diseases (osteoporosis, osteoarthritis, cardiovascular disease, diabetes and cancer)
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Inflammatory Bowel Disease (IBD), encompassing Crohn's disease and Ulcerative Colitis, involves chronic inflammation of the gastrointestinal tract, significantly impacting nutritional status and quality of life. Diet plays a crucial role in both triggering symptoms and managing the disease. Malnutrition, including protein/energy deficits, weight loss, and specific micronutrient deficiencies (e.g., iron, B12, vitamin D, and zinc), is prevalent due to reduced intake, malabsorption, increased requirements, and drug–nutrient interactions. Nutritional assessment is therefore fundamental in IBD care. Dietary interventions are key components of management, ranging from exclusive enteral nutrition (EEN) for inducing remission, particularly in pediatric Crohn's disease, to modified food-based diets aimed at symptom control and potentially maintaining remission. Strategies like low-FODMAP diets, specific carbohydrate diets, and adjustments in fiber and fat intake require careful consideration and individualization. Registered Dietitians are essential members of the multidisciplinary team, providing personalized medical nutrition therapy, guiding patients through complex dietary modifications, addressing nutritional adequacy, and supporting long-term dietary adherence. Further research is needed, but optimizing nutritional care remains paramount for improving clinical outcomes, managing symptoms, and enhancing the overall well-being of individuals living with IBD.

Prof. Dr. Bahram H. Arjmandi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Dietetics is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • inflammatory bowel disease (IBD)
  • Crohn’s disease
  • ulcerative colitis
  • personalized nutrition
  • dietary interventions
  • medical nutrition therapy
  • nutritional assessment
  • malnutrition in IBD
  • micronutrient deficiencies
  • exclusive enteral nutrition (EEN)

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

12 pages, 250 KB  
Review
Dietary and Medical Management of Small-Intestinal Bacterial Overgrowth: A Narrative Review
by Daniel J. Griffith, Stephen Ardouin, Laura Cramp and Sheldon C. Cooper
Dietetics 2026, 5(1), 10; https://doi.org/10.3390/dietetics5010010 - 6 Feb 2026
Viewed by 2100
Abstract
Small-intestinal bacterial overgrowth (SIBO) is defined by an excessive microbial presence in the small intestine and is associated with a range of gastrointestinal symptoms. Its management remains complex due to diagnostic limitations and high recurrence rates following treatment. A narrative review was conducted [...] Read more.
Small-intestinal bacterial overgrowth (SIBO) is defined by an excessive microbial presence in the small intestine and is associated with a range of gastrointestinal symptoms. Its management remains complex due to diagnostic limitations and high recurrence rates following treatment. A narrative review was conducted using MEDLINE (PubMed) and Cochrane databases to identify relevant studies published between 1984 and 2024. Search terms included small intestinal bacterial overgrowth SIBO, FODMAP, probiotics, prebiotics, synbiotics, and low-carbohydrate diets. Reference lists were also screened for additional studies. Antibiotics, particularly rifaximin, are commonly used for SIBO treatment but recurrence is frequent. Dietary strategies, such as low-FODMAP and low-carbohydrate diets, may help reduce symptoms, especially in patients with complications like D-lactic acidosis. Evidence for biotic agents (probiotics, prebiotics, synbiotics) is mixed, with limited high-quality studies and inconsistent outcomes. Some probiotic strains show symptom improvement, but effects on breath-test results are variable. A tailored, multidisciplinary approach combining dietary and medical therapies may offer optimal symptom control in SIBO. However, heterogeneity in study designs and limited evidence highlight the need for further research to inform standardised, evidence-based clinical practice. Full article
Back to TopTop